XML 40 R29.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Stock Options and Restricted Stock Units (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Stock Options and Restricted Stock Units |
Schedule of stock-based compensation expense | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended
​ | ​ | March 31,
​ |  | 2024 |  | 2023
Direct operating costs | ​ | $ | 84 | ​ | $ | 63
Selling and administrative expenses | ​ |  | 950 | ​ |  | 899
Total stock-based compensation | ​ | $ | 1,034 | ​ | $ | 962
Schedule of weighted-average fair value of the options granted, and weighted-average assumptions | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended March 31, | ​
​ |  | 2024 |  | 2023 | ​
Weighted average fair value of options granted | ​ | $ | - | ​ | $ | 1.79 | ​
Risk-free interest rate | ​ | ​ | - | ​ | ​ | 3.88 | %
Expected term (years) | ​ | ​ | - | ​ | ​ | 3.0 | ​
Expected volatility factor | ​ | ​ | - | ​ | ​ | 79.95 | %
Expected dividends | ​ | ​ | - | ​ | ​ | - | ​
Equity Plans |
Stock Options and Restricted Stock Units |
Schedule of stock option activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | Weighted-Average |  | ​
​ | ​ | Number of |  | Weighted - Average |  | Remaining Contractual | ​ | Aggregate
​ |  | Options |  | Exercise Price |  | Term (years) |  | Intrinsic Value
Outstanding at January 1, 2024 |  | 5,339,162 | ​ | $ | 3.22 |  | 6.38 |  | $ | 28,640,009
Granted |  | - | ​ |  | - |  | - |  | ​ | -
Exercised |  | - | ​ |  | - |  | - |  | ​ | -
Forfeited/Expired |  | (2,334) | ​ |  | 6.96 |  | - |  | ​ | -
Outstanding at March 31, 2024 |  | 5,336,828 | ​ | $ | 3.21 |  | 6.13 | ​ | $ | 18,364,840
​ |  | ​ | ​ |  | ​ |  | ​ | ​ |  | ​
Exercisable at March 31, 2024 |  | 3,552,030 | ​ | $ | 2.28 | ​ | 5.22 | ​ | $ | 15,528,015
​ |  | ​ | ​ |  | ​ |  | ​ | ​ |  | ​
Vested and Expected to Vest at March 31, 2024 |  | 5,336,828 | ​ | $ | 3.21 |  | 6.13 | ​ | $ | 18,364,840
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Weighted-Average |  | ​ | ​
​ | ​ | Number of | ​ | Weighted - Average | ​ | Remaining Contractual | ​ | Aggregate
​ | ​ | Options | ​ | Exercise Price | ​ | Term (years) | ​ | Intrinsic Value
Outstanding at January 1, 2023 | ​ | 6,690,490 | ​ | $ | 3.09 | ​ | 7.19 | ​ | $ | 5,989,709
Granted* |  | 25,000 |  | ​ | 3.31 |  | - |  | ​ | -
Exercised |  | (148,167) |  | ​ | 2.31 |  | - |  | ​ | -
Forfeited/Expired |  | (64,666) |  | ​ | 6.96 |  | - |  | ​ | -
Outstanding at March 31, 2023 |  | 6,502,657 | ​ | $ | 3.07 |  | 6.94 | ​ | $ | 35,414,546
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable at March 31, 2023 |  | 4,041,942 | ​ | $ | 2.03 |  | 5.87 | ​ | $ | 26,301,295
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Vested and Expected to Vest at March 31, 2023 |  | 6,502,657 | ​ | $ | 3.07 |  | 6.94 | ​ | $ | 35,414,546
​ *Includes 25,000 stock granted to a non-employee member of the Company’s advisory board. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Weighted-Average | ​ | ​
​ | ​ | Number of | ​ | Weighted - Average | ​ | Remaining Contractual | ​ | Aggregate
​ |  | Options |  | Exercise Price |  | Term (years) |  | Intrinsic Value
Outstanding at January 1, 2024 |  | 923,571 | ​ | $ | 3.41 |  | 8.76 |  | $ | 4,786,252
Granted |  | - | ​ |  | - |  | - |  | ​ | -
Exercised |  | - | ​ |  | - |  | - |  | ​ | -
Forfeited/Expired |  | (5,334) | ​ |  | 3.41 |  | - |  | ​ | -
Outstanding at March 31, 2024 |  | 918,237 | ​ | $ | 3.41 |  | 8.52 | ​ | $ | 2,946,506
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable at March 31, 2024 |  | 386,209 | ​ | $ | 3.34 |  | 8.49 | ​ | $ | 1,258,907
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Vested and Expected to Vest at March 31, 2024 |  | 918,237 | ​ | $ | 3.41 |  | 8.52 | ​ | $ | 2,946,506
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | Weighted-Average |  | ​ | ​
​ | ​ | Number of | ​ | Weighted - Average | ​ | Remaining Contractual | ​ | Aggregate
​ | ​ | Options | ​ | Exercise Price | ​ | Term (years) | ​ | Intrinsic Value
Outstanding at January 1, 2023 |  | 1,027,500 | ​ | $ | 3.46 |  | 9.75 |  | $ | -
Granted |  | - | ​ |  | - |  | - |  | ​ | -
Exercised |  | - | ​ |  | - |  | - |  | ​ | -
Forfeited/Expired |  | (33,500) | ​ |  | 3.41 |  | - |  | ​ | -
Outstanding at March 31, 2023 |  | 994,000 | ​ | $ | 3.46 |  | 9.51 | ​ | $ | 5,051,370
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable at March 31, 2023 |  | 31,250 | ​ | $ | 5.20 |  | 9.29 | ​ | $ | 104,500
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Vested and Expected to Vest at March 31, 2023 |  | 994,000 | ​ | $ | 3.46 |  | 9.51 | ​ | $ | 5,051,370
Restricted Stock Units |
Stock Options and Restricted Stock Units |
Summary of restricted stock under the company's plan | ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Number of |  | Weighted-Average
​ | ​ | Restricted Stock | ​ | Grant Date
​ |  | Units |  | Fair Value
Unvested at January 1, 2024 | ​ | 749,756 | ​ | $ | 5.77
Granted |  | - |  | ​ | -
Vested |  | - |  | ​ | -
Forfeited/Expired |  | (995) |  | ​ | 8.29
Unvested at March 31, 2024 |  | 748,761 | ​ | $ | 5.78
​
​ | ​ | ​ | ​ | ​ | ​
​ |  | Number of |  | Weighted-Average
​ | ​ | Restricted Stock | ​ | Grant Date
​ | ​ | Units | ​ | Fair Value
Unvested at January 1, 2023 |  | 700,000 | ​ | $ | 5.59
Granted |  | - | ​ |  | -
Vested |  | - | ​ |  | -
Forfeited/Expired |  | - | ​ |  | -
Unvested at March 31, 2023 |  | 700,000 | ​ | $ | 5.59

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | inod_StockOptionsLineItems
Namespace Prefix: | inod_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=inod_EquityPlansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |